MDxHealth’s SelectMDx Study Published in European Urology

Data validates ‘liquid biopsy’ test’s ability to identify men at risk for aggressive cancer IRVINE, CA, and HERSTAL, BELGIUM – April 25, 2016 – MDxHealth SA (Euronext: MDXH.BR), today announced that data validating the clinical...

argenx receives milestone payment in LEO Pharma collaboration

Breda, the Netherlands / Ghent, Belgium – argenx (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced...